The accompanying notes are an integral part of these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1.
|
BASIS OF FINANCIAL STATEMENT PRESENTATION
|
The accompanying unaudited consolidated financial statements for the three months ended May 5, 2018 and April 29, 2017 have been prepared in accordance with the requirements for Form 10-Q and Article 10 of Regulation S-X, and accordingly, certain information and footnote disclosures have been condensed or omitted. See the Company’s Annual Report on Form 10-K as of and for the year ended February 3, 2018 for Destination Maternity Corporation and subsidiaries (the “Company” or “Destination Maternity”) as filed with the Securities and Exchange Commission (“SEC”) for additional disclosures including a summary of the Company’s accounting policies.
In the opinion of management, the consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. Since the Company’s operations are seasonal, the interim operating results of the Company may not be indicative of operating results for the full year.
The Company operates on a 52/53 week fiscal year ending on the Saturday nearest January 31 of each year. References to the Company’s fiscal 2018 refer to the 52 week fiscal year, or periods within such fiscal year, which began February 4, 2018 and will end February 2, 2019. References to the Company’s fiscal 2017 refer to the 53 week fiscal year, or periods within such fiscal year, which began January 29, 2017 and ended February 3, 2018.
2
.
|
EARNINGS PER SHARE (“EPS”) AND DIVIDENDS
|
Basic net income (loss) (or earnings) per share (“Basic EPS”) is computed by dividing net income (loss) by the weighted average number of common shares outstanding, excluding restricted stock awards for which the restrictions have not lapsed. Diluted net income (loss) (or earnings) per share (“Diluted EPS”) is computed by dividing net income (loss) by the weighted average number of common shares outstanding, after giving effect to the potential dilution, if applicable, from the assumed lapse of restrictions on restricted stock and deferred stock unit awards, and from shares of common stock resulting from the assumed exercise of outstanding stock options. Common shares issuable in connection with the award of performance-based restricted stock units (“RSUs”) are excluded from the calculation of EPS until the RSUs’ performance conditions are achieved and the shares in respect of the RSUs become issuable (see Note 13).
The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts):
|
|
Three Months Ended
|
|
|
|
May 5, 2018
|
|
|
April 29, 2017
|
|
|
|
Net
Income
|
|
|
Shares
|
|
|
EPS
|
|
|
Net
Loss
|
|
|
Shares
|
|
|
EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
$
|
214
|
|
|
|
13,839
|
|
|
$
|
0.02
|
|
|
$
|
(1,142
|
)
|
|
|
13,748
|
|
|
$
|
(0.08
|
)
|
Incremental shares from the assumed exercise of outstanding stock options
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Incremental shares from the assumed lapse of restrictions on restricted stock and deferred stock unit awards
|
|
|
—
|
|
|
|
124
|
|
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Diluted EPS
|
|
$
|
214
|
|
|
|
13,963
|
|
|
$
|
0.02
|
|
|
$
|
(1,142
|
)
|
|
|
13,748
|
|
|
$
|
(0.08
|
)
|
In addition to performance-based RSUs, for the three months ended May 5, 2018 stock options and unvested restricted stock totaling approximately 1,436,000 shares were excluded from the calculation of Diluted EPS as their effect would have been antidilutive. Stock options, unvested restricted stock and unvested deferred stock units totaling approximately 1,166,000 shares of the Company’s common stock were outstanding as of April 29, 2017 but were not included in the computation of Diluted EPS for the three months ended April 29, 2017 due to the Company’s net loss. Had the Company reported a profit for the three months ended April 29, 2017 the weighted average number of dilutive shares outstanding for computation of Diluted EPS would have been approximately 13,776,000.
8
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
During the three months ended
May 5
, 201
8
and
April
29
, 201
7
,
$
1,000
and
$4,000
, respectively,
of p
reviously declared and undistributed dividends, for which payment was subject to completion of service requirements under restricted stock awards, were forfeited back to the Company in connection with the cancellation of the awards.
Trade receivables are recorded based on revenue recognized for sales of the Company’s merchandise and for other revenue earned by the Company through its marketing partnership programs and international franchise agreements, and are non-interest bearing. The Company evaluates the collectability of trade receivables based on a combination of factors, including aging of trade receivables, write-off experience, analysis of historical trends and expectations of future performance. An allowance for doubtful accounts is recorded for the amount of trade receivables that are considered unlikely to be collected. When the Company’s collection efforts are unsuccessful, uncollectible trade receivables are charged against the allowance for doubtful accounts. As of May 5, 2018 and February 3, 2018 the Company’s trade receivables were net of allowance for doubtful accounts of $166,000 and $166,000, respectively.
Inventories were comprised of the following (in thousands):
|
|
May 5, 2018
|
|
|
February 3, 2018
|
|
|
|
|
|
|
|
|
|
|
Finished goods
|
|
$
|
65,782
|
|
|
$
|
70,687
|
|
Work-in-progress
|
|
|
315
|
|
|
|
182
|
|
Raw materials
|
|
|
322
|
|
|
|
387
|
|
|
|
$
|
66,419
|
|
|
$
|
71,256
|
|
5.
|
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
|
Accrued expenses and other current liabilities were comprised of the following (in thousands):
|
|
May 5, 2018
|
|
|
February 3, 2018
|
|
|
|
|
|
|
|
|
|
|
Employee compensation and benefits
|
|
$
|
5,815
|
|
|
$
|
7,133
|
|
Insurance, primarily self-insurance reserves
|
|
|
5,099
|
|
|
|
5,048
|
|
Deferred rent
|
|
|
3,010
|
|
|
|
3,211
|
|
Sales and use taxes
|
|
|
3,111
|
|
|
|
2,638
|
|
Gift certificates and store credits
|
|
|
2,858
|
|
|
|
3,385
|
|
Product return reserve
|
|
|
3,246
|
|
|
|
2,799
|
|
Accounting and legal
|
|
|
1,264
|
|
|
|
714
|
|
Accrued property and equipment additions
|
|
|
251
|
|
|
|
218
|
|
Income taxes payable
|
|
|
55
|
|
|
|
—
|
|
Other
|
|
|
6,393
|
|
|
|
6,515
|
|
|
|
$
|
31,102
|
|
|
$
|
31,661
|
|
After completion of a debt refinancing on February 1, 2018 the Company has in place a $50,000,000 senior secured revolving credit facility (the “Credit Facility”), which was amended and restated in connection with the issuance of the Company’s $25,000,000 Term Loan (see Note 7). The Company’s previous $70,000,000 Credit Facility had been in place since March 25, 2016. In connection with the Term Loan financing the maturity date of the Credit Facility was extended to January 31, 2023 and certain availability reserves were reduced or eliminated. Proceeds from advances under the Credit Facility, subject to certain restrictions, may be used to provide financing for working capital, letters of credit, capital expenditures, and other general corporate purposes.
9
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
The Credit Facility contains various affirmative and negative covenants and representations and warranties including the requirement that the Company maintain Excess Availability (as defined in the related Credit Agreement) of more than the greater of 10%
of the Combined Loan Caps (as defined in the related Credit Agreement) and $7,000,000. In the event that the outstanding balance of the Term Loan exceeds the Term Loan Borrowing Base (as defined in the related Term Loan Agreement) then a reserve will be im
posed against availability under the Credit Facility. The Credit Facility is secured by a security interest in the Company’s trade receivables, inventory, letter of credit rights, cash, intangibles and certain other assets. The interest rate on outstanding
borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%. The Company also pays an unused line fee under the Credit Facility of 0.25% per annum.
Any amounts outstanding under the Credit Facility may be accelerated and become due and payable immediately and all loan and letter of credit commitments thereunder may be terminated upon an event of default and expiration of any applicable cure period. Events of default include: 1) nonpayment of obligations due under the subject loan agreement and related loan documents, 2) cross-defaults to other indebtedness and documents, 3) failure to perform any covenant or agreement contained in the subject loan agreement, 4) material misrepresentations, 5) failure to pay, or certain other defaults under, other material indebtedness of the Company, 6) certain bankruptcy or insolvency events, 7) a change of control, 8) indictments of the Company or senior management in a material forfeiture action, 9) default under certain material contracts to the extent such termination or default has or could reasonably be expected to have a material adverse effect, and 10) customary ERISA defaults, among others.
In connection with the original execution and subsequent amendments of the Credit Facility, the Company incurred deferred financing costs of $1,280,000 including $107,000 paid in fiscal 2017. These deferred financing costs are being amortized over the term of the Credit Facility agreement and are included in “interest expense, net” in the consolidated statements of operations.
As of May 5, 2018, the Company had $15,200,000 in outstanding borrowings under the Credit Facility, $7,327,000 in letters of credit and $18,796,000 of availability based on the Company’s Borrowing Base formula and availability reserve requirements. As of April 29, 2017, the Company had $2,100,000 in outstanding borrowings under the Credit Facility, $5,827,000 in letters of credit and $14,729,000 of availability. For the three months ended May 5, 2108 and April 29, 2017 borrowings had a weighted interest rate of 3.60% and 3.11% per annum, respectively. During the three months ended May 5, 2018 and April 29, 2017 the Company’s average levels of direct borrowings were $19,436,000 and $11,138,000, respectively, and the Company’s maximum borrowings were $27,400,000 and $15,700,000, respectively.
On February 1, 2018 (the “Closing Date”) the Company entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25,000,000 and matures on January 31, 2023 (the “Term Loan”). On the Closing Date the Company borrowed $22,500,000 net of fees against the Term Loan and used the proceeds, in addition to $3,600,000 borrowed under its Credit Facility (see Note 6) to pay off the $22,999,000 balance of the Company’s then existing term loan (the “Prior Term Loan”) and $3,226,000 of fees and interest associated with the refinancing transaction. The Term Loan provides for an additional loan of $2,500,000 which can be borrowed at the Company’s discretion within a period of 45 days after delivery to the lender of the Company’s first quarter fiscal 2018 financial statements and satisfaction of certain other requirements. There is a minimum excess availability requirement of the greater of 10% of the Combined Loan Cap, as defined in the Term Loan Agreement, or $7,000,000.
The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%. The Company is required to make minimum repayments of the principal amount of the Term Loan in quarterly installments of $312,500 commencing on July 31, 2018, with the remaining outstanding balance payable on the maturity date. Additionally, the Term Loan can be prepaid at the Company's option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date.
10
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
The Term Loan is secured by a security
interest in substantially all of the assets of the Company, including accounts receivable, inventory, equipment, letter of credit rights, cash, intellectual property and other intangibles, and certain other assets. The security interest granted to the Term
Lenders is, in certain respects, subordinate to the security interest granted to the Credit Facility Lender. The Term Loan Agreement prohibits the payment of dividends or share repurchases by the Company for three years and imposes certain restrictions on
the Company's ability to, among other things, incur additional indebtedness and enter into other various types of transactions.
On March 25, 2016 the Company entered into a Term Loan Agreement Credit Agreement (the “Prior Term Loan Agreement”) for the Company’s $32,000,000 Prior Term Loan that had a maturity date of March 25, 2021. The proceeds of the Prior Term Loan were used to repay a portion of the indebtedness that was outstanding under our credit facility at that time. The interest rate on the Prior Term Loan was equal to a LIBOR rate (with a 1.0% LIBOR floor) plus 7.5%. We were required to make minimum repayments of the principal amount in quarterly installments of $800,000 with the remaining outstanding balance payable on the maturity date. As amended on December 19, 2016 and April 7, 2017, the Prior Term Loan Agreement contained various minimum excess availability requirements including $5,000,000 against availability under our Credit Facility that was reduced dollar for dollar for prepayments of the Prior Term Loan, and an amount equal to the greater of 10% of the Combined Loan Cap (as defined in the Credit Facility Agreement) or $10,000,000.
In connection with the execution of the Term Loan Agreement, the Prior Term Loan Agreement and subsequent amendments, the Company incurred deferred financing costs of $4,557,000. Of this amount, the unamortized balance of $1,542,000 in deferred financing costs incurred in connection with the Prior Term Loan were written off upon entering into the Term Loan and charged to loss on extinguishment of debt in our consolidated statements of operations. There were $2,460,000 of deferred financing costs incurred in connection with the Term Loan. These deferred financing costs are reflected as a direct deduction from the Term Loan liability in the consolidated balance sheets and are being amortized over the term of the Term Loan Agreement. The amortization is included in “interest expense, net” in the consolidated statements of operations.
As of May 5, 2018, and April 29, 2017 there was $22,500,000 and $29,600,000, respectively, of principal outstanding under the Term Loan and Prior Term Loan.
As of May 5, 2018, and April 29, 2017 there was $5,284,000 and $8,562,000, respectively, outstanding under a five-year equipment financing arrangement with the Company’s Credit Facility bank. The equipment note bears annual interest at 3.38%, with payments of $272,000 (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at the Company’s distribution facility in Florence, New Jersey. Any amounts outstanding under the equipment note may be accelerated and become due and payable immediately upon an event of default and expiration of any applicable cure period. The specified events of default are substantially the same as those in the Credit Facility agreement (see Note 6).
On June 6, 2017 the Company received $3,401,000 in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software. Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36. At the end of the leaseback term, the Company has the option to extend the lease for an additional year or to repurchase the financed property for a price to be agreed. All of the proceeds from the transaction were used to prepay a portion of the Company’s Term Loan. As of May 5, 2018, there was $2,287,000 of principal outstanding under this financing arrangement.
8.
|
FAIR VALUE MEASUREMENTS
|
The accounting standard for fair value measurements defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a framework for measuring fair value focused on exit price and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements as follows:
|
•
|
Level 1 – Quoted market prices in active markets for identical assets or liabilities
|
|
•
|
Level 2 – Observable market-based inputs or inputs that are corroborated by observable market data
|
|
•
|
Level 3 – Unobservable inputs that are not corroborated by market data
|
11
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
At bo
th
May
5
, 201
8
and
February
3
, 201
8
,
the Company had cash equivalents of $4,000. The Company’s cash equivalents consist of investments in money market funds for which the carrying value approximates fair value (based on Level 1 inputs) due to the short-term nature of those instruments. The c
arrying values of trade receivables and accounts payable approximate fair value due to the short-term nature of those instruments.
The Company’s Credit Facility has variable interest rates that are tied to market indices. As of May 5, 2018, and February 3, 2018 the Company had $15,200,000 and $8,000,000, respectively, of direct borrowings outstanding under the Credit Facility. The carrying value of the Company’s Credit Facility borrowings approximates fair value as the variable interest rates approximate current market rates, which the Company considers to be Level 2 inputs.
The Company’s Term Loan, which represents a significant majority of the Company’s long-term debt, bears interest at variable rates, which adjust based on market conditions with a minimum annual rate of 9.00%. The carrying value of the Company’s Term Loan approximates fair value as the variable interest rates approximate current market rates
for similar instruments available to companies with comparable credit quality, which the Company considers to be Level 2 inputs. The fair value of the Company’s fixed-rate equipment notes were determined using a discounted cash flow analysis based on interest rates currently available to the Company, which the Company considers to be Level 2 inputs. The difference between the carrying value and fair value of long-term debt held by the Company with a fixed rate of interest is not material.
The following table disaggregates the Company’s net sales by major source (in thousands):
|
|
Three Months Ended
|
|
|
May 5, 2018
|
|
|
April 29, 2017
|
Net Sales
|
|
|
|
|
|
|
|
Retail stores
|
|
$
|
62,987
|
|
|
$
|
70,848
|
Leased departments
|
|
|
9,989
|
|
|
|
11,563
|
Total retail locations
|
|
|
72,976
|
|
|
|
82,411
|
Ecommerce
|
|
|
25,482
|
|
|
|
17,840
|
Marketing partnerships
|
|
|
3,935
|
|
|
|
4,350
|
Wholesale and franchisee
|
|
|
834
|
|
|
|
1,825
|
Total net sales
|
|
$
|
103,227
|
|
|
$
|
106,426
|
The Company’s performance obligations consist primarily of transferring control of merchandise to customers. Retail and ecommerce sales are recognized upon transfer of control, which occurs when merchandise is taken at point-of-sale for a retail transaction or upon receipt of shipment for an ecommerce transaction. Sales are reported net of returns and sales taxes. Shipping and handling fees billed to customers are recognized in net sales when control of the underlying merchandise is transferred to the customer.
The Company earns revenue through a variety of marketing partnership programs utilizing the Company’s opt-in customer database and various in-store marketing initiatives focused on baby and parent-related products and services. Revenue from these activities is recognized when the goods or services are provided.
Sales of product to the Company’s wholesale customers and international franchisees are recognized upon transfer of control which is primarily when the product is shipped. Franchise fees are recorded by the Company when all material services have been performed or in the case of royalties earned on sales of product, in the period when the franchisee sells product to their retail customer.
In the first quarter of fiscal 2018 the Company received notification from a stockholder group of the nomination of a slate of alternative nominees for election to the Company’s Board of Directors at the Annual Meeting of Stockholders that was held on May 23, 2018 (the “2018 Proxy Contest”). During the three months ended May 5, 2018 the Company incurred $886,000 of charges related to the proxy solicitation.
12
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
During the fourth quarter of fiscal 2015 the Company
entered into an Agreement and Plan of Merger
(the “Merger Agreement”) with t
he Company’s largest shareholder
, Orchestra, a France-based retailer of children’s wear
, to complete a proposed business combination (“the Merger”).
During the second quarter of fiscal 2017 the parties determined that is was
in the best interest of their respective stockholders to terminate the Merger and on July 27, 2017, the Company, Orchestra, and certain other affiliates of Orchestra entered into a
T
ermination
A
greement
(“the Termination Agreement”).
In connection with
the
T
ermination
A
greement, Orchestra and the Company agreed to reimburse each other for certain costs incurred in connection with their effort to implement the Merger Agreement.
During the three months ended April
29
, 201
7
the Company incurred $
814
,000 of
charges
related to the
proposed merger
.
In an effort to improve revenue and profitability over the last several years the Company has engaged in a series of management and organizational changes. In connection therewith, the Company retained a consulting firm to review its costs and business strategy. Also, the Company’s Board of Directors authorized changes to the Company’s chief executive function including the resignation of Anthony M. Romano as our Chief Executive Officer and President (“Former CEO”), the September 17, 2017 appointment of B. Allen Weinstein, an independent member of our Board since 2010, as Interim Chief Executive Officer (“Interim CEO”), and the January 2, 2018 appointment of Melissa Payner-Gregor, an independent member of our board since 2009, (replacing Mr. Weinstein) as Interim CEO. The Company also paid one-time retention bonuses with service conditions to certain key management personnel which are being recorded over the service period, while reducing its overall headcount to create a more efficient and effective operating structure.
During the three months ended May 5, 2018 and April 29, 2017 the Company incurred $264,000 and $3,000, respectively, of charges related to these management and organizational changes.
A summary of the charges incurred in connection with the proposed business combination and the management and organizational changes is as follows (in thousands):
|
|
Three Months Ended
|
|
|
|
May 5, 2018
|
|
|
April 29, 2017
|
|
|
|
|
|
|
|
|
|
|
Proxy Contest and Proposed Merger
|
|
|
|
|
|
|
|
|
Proxy contest
|
|
$
|
886
|
|
|
$
|
—
|
|
Proposed merger
|
|
|
—
|
|
|
|
814
|
|
Total proxy solicitation and proposed merger
|
|
|
886
|
|
|
|
814
|
|
|
|
|
|
|
|
|
|
|
Management and Organizational Changes
|
|
|
|
|
|
|
|
|
Severance and related benefits
|
|
|
252
|
|
|
|
3
|
|
Consulting fees
|
|
|
12
|
|
|
|
—
|
|
Total management and organizational changes
|
|
|
264
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
Total other charges
|
|
$
|
1,150
|
|
|
$
|
817
|
|
1
1
.
|
GOVERNMENT INCENTIVES
|
In fiscal 2015 the Company completed the relocation of its corporate headquarters and distribution operations from Philadelphia, Pennsylvania to southern New Jersey. To partially offset the costs of these relocations, the Board of the New Jersey Economic Development Authority (“NJEDA”) approved the Company for an incentive package of up to $40,000,000 in benefits under the Grow New Jersey Assistance Program (“Grow NJ”) in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The award provides annually over a ten-year period up to $7,000 per eligible new full-time job, as defined under Grow NJ, with a requirement that at least 100 eligible jobs be created and subject to an annual award limit of $4,000,000.
The Grow NJ award requires an annual compliance report that includes certification of average annual employment figures after the end of each fiscal year. After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period. The Company believes the likelihood of any recapture and repayment is remote.
13
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
The annual benefit from the Grow NJ award available to the Company is expected to significantly exceed the Company
’s annual income tax liability to the State of New Jersey. In order to maximize the realizable value of the incentive package, in December 2013 the Company entered into an agreement with a third party to sell 75% or more of the annual income tax credits aw
arded to the Company. The Company recognizes its Grow NJ award on an annual basis for each fiscal year based on the realizable value of the award earned and expected to be received, primarily from the sale of the income tax credits, net of any associated c
osts. The Grow NJ award is reflected in the Company’s consolidated financial statements as a reduction to the costs incurred by the Company in c
onnection with the relocations.
T
he expected realizable amount of the Grow NJ award is included in the consolida
ted balance sheet in deferred income taxes.
As of May 5,
2018
,
the Company had recorded a deferred tax asset of $2,829,000 related to the NJ Grow award earned in fiscal 2017, the cash proceeds of which it expects to receive in the second quarter of fiscal
2018.
In April 2017
the Company received $3,251,000 cash proceeds, net of costs, from the receipt and subsequent sale of the $3,612,000 tax credit certificate earned for fiscal 2016. During
the first quarter of fiscal
201
8
and fiscal
201
7
the Company recog
nized
$7
10
,000
and
$
718
,000
, respectively,
of cost reduction related to the Grow NJ award, of which
$71
5
,000
and
$7
13
,000
, respectively,
is included in the
c
onsolidated
s
tatement
s
of
o
perations
, including
reduction
s
of cost of goods sold
of
$51
8
,000
and
$51
4
,000
, respectively,
and
reductions of
selling, general and administrative expenses
of
$
197,000
and
$
199
,000,
respectively. Additionally,
$
771
,000
and
$
776
,000
,
is included in the consolidated balance s
heet
s
as of
May
5
, 201
8
and
February
3
, 201
8
,
respectively, as a reduction to overhead in inventory
.
The U.S. Tax Cuts and Jobs Act of 2017 (the “TCJA”) was signed into law on December 22, 2017. The TCJA included a number of changes to the U.S. corporate income tax including a reduction of the corporate income tax rate from 35% to 21% for tax years beginning after December 31, 2017. For fiscal 2018 the Company’s effective federal tax rate is 21%. For fiscal 2017 the Company used a blended effective tax rate of 33.7% which represented the prorated percentage from the TCJA’s January 1, 2018 effective date and our February 3, 2018 fiscal year-end.
The Company is reporting the impact of the TCJA provisionally based on reasonable estimates using currently available information and interpretations. We will continue to refine our reporting within the measurement period provided by Staff Accounting Bulletin No. 118.
Accounting Standards Codification (“ASC”) Topic 740,
Income Taxes
, requires that a valuation allowance be recorded to reduce deferred tax assets when it is more likely than not that the tax benefit of the deferred tax assets will not be realized.
In situations where a three-year cumulative loss condition exists, accounting standards limit the ability to consider projections of future results as positive evidence to assess the realizability of deferred tax assets. In fiscal 2016 the Company’s financial results reflected a three-year cumulative loss. Consequently, in fiscal 2016 the Company recorded a non-cash charge as a valuation allowance against substantially all of its deferred tax assets. Three-year cumulative losses have continued in fiscal 2017 and fiscal 2018, consequently the Company continues to record a valuation allowance against its deferred tax assets.
The Compensation Committee of the Company’s Board of Directors established performance goals for the award of performance-based RSUs for the Company’s executive officers, under the Amended and Restated Destination Maternity Corporation 2005 Equity Incentive Plan, in each of August 2016 and April 2016 (collectively the “Fiscal 2016 Awards”) and April 2015 (the “Fiscal 2015 Awards”). The RSUs earned, if any, under the awards will be based on the Company’s cumulative adjusted EBITDA, as defined in the applicable award agreement (“RSU Adjusted EBITDA”) for a specified three-year period (“Performance Period”). The grant of any RSUs under these awards will generally be further contingent on the continued employment of the executive officers with the Company through the dates on which the shares in respect of these RSUs, if any, are issued following the end of the applicable Performance Periods, as well as the achievement of certain minimum levels of RSU Adjusted EBITDA in the final fiscal year of each applicable Performance Period. The additional RSUs, if any, will be earned on the same terms as the original RSUs.
14
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
The following table sets forth the aggregate mi
nimum, target and maximum RSUs
, that may be earned by the executive officers for each fiscal year award cyc
le.
Awards
|
|
Performance Period
|
|
|
|
Minimum RSUs
|
|
|
|
Target RSUs
|
|
|
|
Maximum RSUs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal 2016 Awards
|
|
January 31, 2016 to February 2, 2019
|
|
|
|
13,698
|
|
|
|
54,789
|
|
|
|
82,185
|
|
Fiscal 2015 Awards
|
|
February 1, 2015 to February 3, 2018
|
|
|
|
15,218
|
|
|
|
30,436
|
|
|
|
45,655
|
|
No RSUs were earned under the Fiscal 2015 Awards as the RSU Adjusted EBITDA for that Performance Period was not achieved. During fiscal 2016 the Company determined that the Fiscal 2016 Awards were unlikely to be earned, even at the minimum level.
During the three months ended May 5, 2018 and April 29, 2017 certain vesting restricted stock awards were net-share settled by the Company such that the Company withheld shares of the Company’s common stock, which had a fair market value equivalent to the minimum statutory obligation for the applicable income and employment taxes for the awards, and the Company remitted the cash value to the appropriate taxing authorities. The total shares withheld in connection with the tax obligations, which were approximately 7,000 and 8,000 shares, respectively, during the three months ended May 5, 2018 and April 29, 2017, are reflected as repurchase of common stock in the accompanying financial statements, and were based on the value of the Company’s common stock on the vesting date. The remaining shares, net of those withheld, were delivered to the award holders. Total payments for tax obligations to the tax authorities were $19,000 and $35,000 for the three months ended May 5, 2018 and April 29, 2017, respectively.
1
4
.
|
RECENT ACCOUNTING PRONOUNCEMENTS
|
a. Newly Adopted Accounting Pronouncements
In May 2017 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09,
Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting
. ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. ASU No. 2017-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted. The Company adopted ASU No. 2017-09 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
In October 2016 the FASB issued ASU No. 2016-16,
Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory
. ASU No. 2016-16 amends the accounting for income taxes and requires the recognition of the income tax consequences of an intercompany asset transfer, other than transfers of inventory, when the transfer occurs. For intercompany transfers of inventory, the income tax effects will continue to be deferred until the inventory has been sold to a third party. ASU No. 2016-16 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years, using a modified retrospective application method through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. Earlier application is permitted. The Company adopted ASU No. 2016-16 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
In August 2016 the FASB issued ASU No. 2016-15,
Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments
. ASU No. 2016-15 clarifies and provides guidance on eight specific cash flow classification issues and is intended to reduce existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU No. 2016-15 is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted, provided that all of the amendments are adopted in the same period. The Company adopted ASU No. 2016-15 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
15
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
In May 2014 the FASB issued ASU No. 2014-09,
Revenue from Contracts with Customers (Topic 606)
. ASU No. 2014-09 requires an entity to recognize revenue for the amount of consideration to which it expects to be entitled for the transfer of promised goods or services to customers. Additionally, ASU No. 2014-09 requires improved disclosures to help us
ers of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized. The standard
replaced
most existing revenue recognition guidance in GAAP when it bec
ame
effective. ASU No. 2014-09 is effective for fin
ancial statements issued for annual reporting periods beginning after December 15, 2016 and interim periods within those years. In August 2015 the FASB issued ASU No. 2015-14,
Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Dat
e
which deferred the effective date of ASU No. 2014-09 by one year, making the guidance effective for fiscal years beginning after December 15, 2017.
Management adopted this guidance on February 3, 2018 using the modified retrospective approach. This ASU required that sales return reserves be presented on a gross basis as a refund liability and an asset for recovery and that the asset be reported separate from inventory on the Company’s consolidated balance sheet. Prior to the adoption of this ASU the Company had recorded its sales return reserve on a gross basis with the asset for recovery recorded as a component of inventory. The impact of adoption on the Company’s consolidated balance sheet as of May 7, 2018 is as follows:
|
|
|
|
|
|
|
|
Excluding
ASU
|
(in thousands)
|
|
As Reported
|
|
ASU 2014-09
Effect
|
|
2014-09
Effect
|
Inventories
|
|
$
|
66,419
|
|
$
|
(1,271
|
)
|
|
67,690
|
Prepaid expenses and other current assets
|
|
|
11,774
|
|
|
1,271
|
|
|
10,503
|
There was no impact from adoption on the Company’s consolidated statements of operations or consolidated statements of cash flow.
b. Not Yet Adopted
In February 2016 the FASB issued ASU No. 2016-02,
Leases (Topic 842)
. ASU No. 2016-02 affects any entity that enters into a lease (as that term is defined in the ASU) and its guidance supersedes Topic 840,
Leases
. As it substantively relates to the Company, ASU No. 2016-02 requires lessees to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position. For finance leases, lessees are required to recognize interest on the lease liability separately from amortization of the right-of-use asset in the statement of comprehensive income and to classify repayments of the principal portion of the lease liability within financing activities and payments of interest on the lease liability and variable lease payments within operating activities in the statement of cash flows. For operating leases, lessees are required to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a generally straight-line basis, and to classify all cash payments within operating activities in the statement of cash flows. In transition, lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU No. 2016-02 is effective for financial statements issued for annual reporting periods beginning after December 15, 2018 and interim periods within those years. Earlier application is permitted.
While the Company is still evaluating this standard, given the significant number of leases the Company is party to, the Company expects this standard will have a material impact on the Company's consolidated financial statements.
1
5
.
|
COMMITMENTS AND CONTINGENCIES
|
From time to time, the Company is named as a defendant in legal actions arising from normal business activities. Litigation is inherently unpredictable, and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, the Company does not believe that the resolution of any pending action will have a material adverse effect on its financial position, results of operations or liquidity.
1
6
.
|
SEGMENT AND ENTERPRISE WIDE DISCLOSURES
|
Operating Segment
. For purposes of the disclosure requirements for segments of a business enterprise, the Company has determined that its business is comprised of one operating segment: the design, manufacture and sale of maternity apparel and related accessories. While the Company offers a wide range of products for sale, the substantial portion of its products are initially distributed through the same distribution facilities, many of the Company’s products are manufactured at common contract manufacturer production facilities, the Company’s products are marketed through a common marketing department, and these products are sold to a similar customer base consisting of expectant mothers.
16
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
Geographic Information
.
Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographi
c area was as follows (in thousands):
|
|
Three Months Ended
|
|
|
|
May 05, 2018
|
|
|
April 29, 2017
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
98,250
|
|
|
$
|
100,429
|
|
Foreign
|
|
|
4,977
|
|
|
|
5,997
|
|
|
|
May 5, 2018
|
|
|
February 3, 2018
|
|
|
|
|
|
|
|
|
|
|
Long-Lived Assets
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
61,867
|
|
|
$
|
65,456
|
|
Foreign
|
|
|
1,538
|
|
|
|
1,643
|
|
Major Customers
.
For the periods presented, the Company did not have any one customer who represented more than 10% of its net sales.
1
7
.
|
INTEREST EXPENSE, NET
|
Interest expense, net was comprised of the following (in thousands):
|
|
Three Months Ended
|
|
|
|
May 5, 2018
|
|
|
April 29, 2017
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
$
|
1,158
|
|
|
$
|
1,005
|
|
Interest income
|
|
|
(1
|
)
|
|
|
(1
|
)
|
Interest expense, net
|
|
$
|
1,157
|
|
|
$
|
1,004
|
|
17